From Product to Patient: Shifting the focus of support programs in oncology
By Amy Grogg, PharmD, Senior Vice President, Strategy & Commercialization, AmerisourceBergen Specialty Group
Empowered by the ease with which they can access information, today’s cancer patients seek a deeper understanding about their diagnoses, underlying diseases or health conditions and potential treatment options, as well as the financial implications of clinical decisions made by their prescribers. But what does it all mean for pharma? In this era of greater healthcare information, transparency and access, manufacturers can find success by engaging patients at an individual level. It’s time for true patient-centricity – a tailored approach to patient support, even for patients that struggle to engage in their own care.
Read More (pdf version)